Infant Formula Testing Market Shows Tremendous Scope With

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
67
Infant Formula Testing Market Shows Tremendous Scope With The Growing Population - IndustryARC

Hyderabad, India, March 15, 2017 (GLOBE NEWSWIRE) -- The report “ Infant Formula Testing Market: By Test Type (Allergens Testing, Adulteration Testing, Nutritional Analysis, Microbiology Testing), By Technology (NMR Spectroscopy, PCR, Chromatography, Mass Spectrometry, Immunoassay) & By Geography-Forecast (2016-2021) ”, published by IndustryARC, estimates that burgeoning Birth Rates and change in lifestyle, is set to open the market in testing for compliance of baby food, notably in Asia-Pacific.

Browse 16 Market Tables, 46 Figures spread through 133 Pages and an in-depth TOC on “ Infant Formula Testing Market 2016-2021 ” http://industryarc.com/Report/228/Global-Infa...eport.html   Scope & Regional Forecast of the Infant Formula Testing Market:

Infant formula testing plays a significant role in checking the quality, nutritional value and ingredients of infant’s food. Infant formula is the food manufactured for feeding to infants and babies with recommended composition of products. It is mandatory to meet the standards and regulations in terms of safety and quality to safeguard the health of new-born babies. Different types of tests are performed such as nutritional analysis, allergens testing, microbiology testing and others to check the quality of the food. Variety of technologies is applied in infant formula testing. Infant formula production is a difficult procedure which involves global raw material supply chain. This market is estimated to grow rapidly during 2016-2022.

Request Sample PDF Brochure @ http://industryarc.com/pdfdownload.php?id=228  

Growth of infant population, increased usage of infant formula products, people lifestyle are the key drivers of global infant formula testing market. Global promotion of infant formula as well as other commercial baby foods along with raising concerns about their impact on the health of infants is fueling the growth of infant formula testing market worldwide. Global infant formula testing market is facing issues in developed countries because of increased imports and reliance on other countries for manufacturing products. Infant formula testing use wide range of technologies for testing which include NMR spectrometry, chromatography, mass spectrometry, immunoassay and others. Amongst all the technologies, NMR spectrometry and immunoassay has the highest CAGR for the forecast period. Microbiology testing is the major segment primarily due to mandatory regulations surrounding testing of harmful pathogens and the polymerase chain reaction is estimated to witness an upsurge due to testing providers’ inclination towards rapid testing methods.

Inquiry before buying report @ http://industryarc.com/inquiry-before-buying.php?id=228  

Prominent Segmentations Involved in the Infant Formula Testing Market: The Infant Formula Testing Market can be broken down into various segmentations on the basis of -

  • Test Type: Allergens Testing, Adulteration testing, Nutritional Analysis, Microbiology Testing and Others.
  • Technology: NMR Spectroscopy, Chromatography, Mass Spectrometry, Polymerase Chain Reaction, Immunoassay and Others.
  • Geographic Location: Americas (U.S, Canada, Brazil, Rest of Americas), Europe (Germany, U.K, Switzerland, France, Italy, Rest of Europe), Asia-Pacific (China, Japan, Australia & New Zealand, India, Rest of APAC) and Rest of the world (Middle East, Africa).

Some of the sample companies profiled in the Infant Formula Testing Market report are as follows:

  • Agilent Technologies, Inc.
  • Covance Inc.
  • Thermo Fisher Scientific Inc.
  • Silliker Inc.
  • Accugen Laboratories, Inc.
  • Intertek Group PLC
  • Eurofins Central Analytical Laboratories
  • ELISA Technologies, Inc.
  • Bureau Veritas S.A.
  • SGS SA

Why buy this report?

  • Get a detailed picture of the Infant Formula Testing Market.
  • Pinpoint growth sectors and identify factors driving change.
  • Understand the competitive environment, the market’s major players and leading brands.
  • A five-year forecast method is used in order to assess how the market is predicted to develop.

Purchase Infant Formula Testing Market Report @ http://industryarc.com/purchasereport.php?id=228  

Browse Related Reports:

Food Safety Testing Market: By Test (Microbiology, Allergen, Pesticides, Fertilizers, GMO Analysis) Technique (PCR, Mass Spectrometry, Chromatography, Others) Food (Meat & Poultry, Dairy Products, Fruits, Vegetables)-Forecast (2017 – 2022) http://industryarc.com/Report/10595/food-safe...arket.html   North America Baby Food Product Market: By Product Type (Cereals, Milk Formula, Prepared, Frozen and Dried Food) By Distribution Channel (Supermarkets/Hypermarkets, Convenience stores, Specialty food stores, Online Retail) - Forecast (2017-2022)   http://industryarc.com/Report/7520/North-amer...arket.html  

About IndustryARC:

IndustryARC is a research and consulting firm that publishes more than 500 Reports Annually in various industries, such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, Life sciences & Healthcare.

IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications of the Market. Our Custom Research Services are designed to provide insights on the constant flux in the global demand-supply gap of markets. Our strong analyst team enables us to meet the client research needs at a very quick speed with a variety of options for your business.

We look forward to support the client to be able to better address customer needs; stay ahead in the market; become the top competitor and get real-time recommendations on business strategies and deals. Contact us to find out how we can help you today.

Media Contact Mr. Sanjay Matthews Business Development Manager Email:  sales@industryarc.com Contact Sales: 1-614-588-8538 (Ext-101) Connect with us on LinkedIn - https://www.linkedin.com/company/industryarc   Know more about IndustryARC Events: http://industryarc.com/events.php  

Scroll down for more posts ▼

Top 10 Most Recent News Articles

GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 120

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 117

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Segway Powersports Ventures into Baja 1000: Ambitions Run High

Updated Category News Views 20

They're gunning for glory in the sands of Baja, folks—Segway Powersports is about to rev up the excitement with its Baja 1000 debut. Never heard before in this legendary race's chronicles, Segway aims to shake up the game with their two brawny Super Villain UTVs. These aren't your run-of-the-pavement ride-ons; they're built for the rough stuff—and if there's a stage...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 439

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cars.com Inducement Awards: New CPO Earns Stock Boost

Updated Category News Views 57

Revving Up With Incentives: A Strategic Move by Cars.com Ever seen a stock maneuver that feels more like a chess play than a plain deal? On November 5, 2026, Cars.com (NYSE: CARS) fired up quite a strategic engine. They handed out a heap of restricted stock units—373,345 to be precise—to Mausam Bhatt, freshly minted as their Chief Product Officer. This isn't just your...

Continue Reading
Tencent Cloud's Edge Platform Shines in New Gartner Report

Updated Category News Views 24

The Breakthrough in Edge Computing Everyone's talking about cloud this and cloud that, but Tencent Cloud is taking things a notch further with its EdgeOne platform. It's not just about storing your files in the sky; it's about having the fastest, most secure delivery possible. Gartner's latest report puts these guys right at the top in their Magic Quadrant for Edge...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 322

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 417

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 302

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 147

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading

Top 5 Most Recently Viewed Articles

Verint's Investor Day: Unveiling Key Innovations in CX Automation

Updated Category News Views 254

Exciting Updates from Verint's Investor Day Event Verint® (Nasdaq: VRNT), known as The CX Automation Company™, has recently held its much-anticipated Investor Day, highlighting significant advancements and outlined strategies aimed at shaping the future of customer experience (CX). The event kicked off with CEO Dan Bodner expressing enthusiasm about discussing the...

Continue Reading
Tri Pointe Homes, Inc. Delivers Strong Q3 2025 Performance

Updated Category News Views 255

Tri Pointe Homes Reports Outstanding Third Quarter Performance Tri Pointe Homes, Inc. (NYSE: TPH), a leading homebuilder in America, has unveiled strong results for the third quarter of 2025, highlighting significant achievements in home deliveries and financial performance. Key Highlights of Q3 2025 The company has reported a total of 1,217 new home deliveries during...

Continue Reading
Main Street Capital Q3 2024 Results Showcase Strong Growth

Updated Category News Views 144

Main Street Capital Reports Impressive Financial Results Main Street Capital Corporation (NYSE: MAIN) is excited to share its financial results for the third quarter of 2024. With solid performance reflected in higher net investment income and a robust capital position, the company demonstrates its commitment to delivering value to shareholders. Highlights from Q3 2024...

Continue Reading
Rathbones Group Plc's Significant Position in Warpaint London

Updated Category News Views 194

Key Disclosure of Rathbones Group Plc In the financial landscape, transparency is of utmost importance, especially when significant interests in securities come to light. Rathbones Group Plc has provided a crucial disclosure as they maintain an interest in relevant securities of Warpaint London Plc, representing over 1% of their shares. This type of disclosure aligns with...

Continue Reading
Anticipated Surge in Electric Trucks Market to $20.32 Billion

Updated Category News Views 149

Overview of the Electric Trucks Market Growth The global electric trucks market is projected to witness significant growth, with estimates indicating an increase of USD 20.32 billion from recent years through to 2028. This growth trajectory shows an impressive compound annual growth rate (CAGR) of approximately 35.44%. The rising demand for fuel-efficient and low-emission...

Continue Reading